NOTICIAS
- Immune aging blueprint offers new clues to fighting cancer
- New cancer frontiers: Could COVID vaccines help make treatments more effective?
- Some allergies may start with cells running short of energy, not immune system misfires
- Malaria antibody protects infants but lowers immune response to R21 vaccine, trial finds
- Why humans get the worst of Ebola virus
- Lyme disease leaves lasting changes in bone marrow, study finds
- A potential pathway to reversing liver fibrosis targets specialized immune cells
- Blocking receptor signals can help treat fibrosis
- Therapeutic antibody protects against all three pathogenic human coronaviruses
- Study identifies key immune mechanism in the brain involved in metabolic control
- Most children labeled allergic to antibiotics may not have an allergy, researchers warn
- Targeting immune overactivity in Down syndrome shows promise in phase 2 clinical trial
- A vaccine for acne? Scientists are working on it
- Dental compound K21 boosts human immune cells’ bacteria-fighting ability in lab tests
- A rare disease reveals a hidden flaw in the immune system
- A new tool to predict T cell behavior and improve immunotherapies
PUBLICACIONES
- Immune aging blueprint offers new clues to fighting cancer
- New cancer frontiers: Could COVID vaccines help make treatments more effective?
- Some allergies may start with cells running short of energy, not immune system misfires
- Malaria antibody protects infants but lowers immune response to R21 vaccine, trial finds
- Why humans get the worst of Ebola virus
- BEAT-SC: randomized, controlled, double-blind phase III study of bevacizumab plus atezolizumab and chemotherapy as first-line treatment of extensive-stage small cell lung cancer
- CD36+ Kupffer cells control postprandial lipid clearance and fuel metabolic dysfunction–associated steatotic liver diseases
- Aging drives distinct chromatin signatures of CD8 T cell dysfunction and the emergence of a unique CD8 Treg cell population
- Wall teichoic acid regulates DNA-triggered innate immune receptor activation by Staphylococcus aureus
- Transglutaminase 2 contributes to bacterial control and inflammatory pathology in Mycoplasma pneumoniae pneumonia
- Immune checkpoint inhibitors in the surgical setting of head and neck squamous cell carcinoma: a review of clinical trials and predictive biomarkers
- Pathological response and tumor-bed immune organization following preoperative immunotherapy in hepatocellular carcinoma
- CRISPR-based functional oncology in colorectal cancer: from genome interrogation to precision therapeutic engineering
- Low-intensity pulsed ultrasound: physical principles, mechanisms, and anti-inflammatory effects
- Metabolic heterogeneity across T-cell states and its implications for immunotherapeutic intervention
- Integrated immunologic surveillance in heart transplantation: from alloimmune risk assessment to precision monitoring
- The estrogen receptor-regulated immunosuppression is responsible for ascites disease in yellow catfish (Pelteobagrus fulvidraco) during estrogen treatment
- Computational image analysis for the detection and characterisation of circulating tumour cells
- Remodelling the tumour microenvironment to potentiate immunotherapy in early-stage triple-negative breast cancer: mechanisms, rational combinations, and biomarker-driven stratification
- Practical strategies for postmarketing vaccine evaluation in the real world
- Polymorphonuclear neutrophils modulate the responses of human immune cells to influenza vaccine in an in vitro blood cell culture system
- Editorial: Precision medicine and targeted therapies in gastrointestinal and genitourinary solid tumors
- Establishing a comprehensive preclinical platform to study radioresistance in triple-negative breast cancer
- Editorial: New challenges in pediatric immunohematology
- Ivonescimab combined with hypofractionated stereotactic reirradiation for recurrent WHO grade 4 glioma: protocol for a single-arm phase II trial
- Baseline and early on-treatment immune profiling in patients with pleural mesothelioma on dual immune checkpoint inhibition
- Postherpetic neuralgia-associated secretory protein biomarkers related to major depressive disorder: an integrated bioinformatics, clinical, and experimental study
- Antibody profiling in quantity and avidity across SARS-CoV-2 variants identifies distinct long Covid endotypes
- Immunogenicity and protection against omicron subvariants induced by XBB.1.5 Spike DNA vaccine
- Longitudinal blood multi-omics identifies immune-inflammatory trajectories associated with recurrence and response during immune checkpoint inhibitor-containing therapy in pancreatic ductal adenocarcinoma
- Single-cell immunophenotyping reveals an innate-hyperactive immune continuum observed across autoantibody classes in antisynthetase syndrome that parallels the interferon–complement axis
- Rb1-loaded macrophage-derived extracellular vesicles alleviate corneal alkali injury by remodeling the ALKBH5-PTEN m6A axis and immune-angiogenic microenvironment